{"top_spans": [[2, 2], [4, 8], [10, 10], [11, 15], [11, 16], [16, 16], [18, 18], [20, 21], [20, 22], [24, 24], [24, 29], [26, 26], [26, 29], [27, 27], [28, 28], [28, 29], [30, 30], [32, 32], [33, 33], [35, 35], [37, 37], [38, 38], [38, 41], [38, 44], [38, 45], [39, 41], [39, 45], [47, 48], [47, 54], [52, 52], [52, 54], [52, 57], [56, 57], [56, 59], [57, 57], [58, 58], [60, 60], [62, 65], [62, 66], [63, 66], [65, 65], [65, 66], [65, 73], [68, 73], [72, 72], [72, 73], [74, 74], [75, 80], [75, 82], [75, 83], [76, 83], [78, 87], [82, 82], [82, 87], [83, 83], [85, 85], [87, 87], [88, 88], [88, 90], [89, 90], [93, 93], [98, 98], [118, 118], [125, 125], [127, 127], [131, 131], [134, 134], [141, 141], [141, 142], [145, 145], [146, 146], [152, 153], [166, 166], [176, 179], [176, 180], [176, 184], [190, 193], [195, 195], [196, 196], [197, 197], [199, 199], [201, 205]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["eyepoint", "pharmaceuticals", "reports", "fiscal", "first", "quarter", "2019", "financial", "results", "and", "highlights", "recent", "clinical", "and", "operational", "developments", "-yutiq", "\u2122", "approved", "by", "u", "s", "fda", "anticipated", "launch", "in", "calendar", "1q19-", "-exclusive", "license", "granted", "to", "ocumension", "therapeutics", "to", "develop", "and", "commercialize", "eyepoint", "three", "-", "year", "micro", "-", "insert", "product", "using", "the", "durasert", "\u2122", "technology", "for", "posterior", "segment", "uveitis", "in", "greater", "china-", "-commercial", "preparations", "underway", "for", "anticipated", "launch", "of", "dexycu", "\u2122", "in", "the", "first", "half", "of", "calendar", "year", "2019-", "-cash", "injection", "of", "28", "9", "million", "from", "warrant", "exercise-", "-conference", "call", "and", "webcast", "today", "november", "6th", "at", "8", "00", "am", "et-", "john", "landis", "macau", "u", "s", "food", "and", "drug", "administration", "twitter", "aao", "linkedin", "food", "and", "drug", "administration", "eu", "alimera", "sciences", "il", "ocumension", "verisome", "taiwan", "macular", "edema", "securities", "and", "exchange", "commission", "facebook", "watertown", "massachusetts", "journal", "of", "cataract", "refractive", "surgery", "yutiq", "united", "kingdom", "schering", "-", "plough", "corporation", "iluvien", "professional", "services", "dexycu", "greater", "china", "prednisolone", "alimera", "chicago", "u", "s", "mass", "eyepoint", "china", "bausch", "lomb", "psivida", "corp", "pharmacia", "corporation", "european", "union", "nipu", "google", "ma", "fluocinolone", "acetonide", "intravitreal", "nancy", "lurker", "eyepoint", "pharmaceuticals", "inc", "alimera", "sciences", "inc", "the", "upjohn", "company", "posterior", "uveitis", "watertown", "eyepoint", "pharmaceuticals", "president", "and", "chief", "executive", "officer", "recent", "clinical", "and", "operational", "developments", "hong", "kong", "fluocinolone", "acetonide", "ocumension", "therapeutics", "wet", "age", "-", "related", "macular", "degeneration"], "clusters": []}